CRH Medical Corporation announced today that it has signed a product distribution agreement with Rayfield Technologies to sell the Company\'s proprietary hemorrhoid technology, the CRH O\'Regan System(TM), in China.

CRH Medical Corporation announced today that it has signed a product distribution agreement with Rayfield Technologies to sell the Company\'s proprietary hemorrhoid technology, the CRH O\'Regan System(TM), in China.
Rayfield Technologies has developed a successful sales network throughout China. They employ a significant direct sales force in all provinces, with regional offices in Beijing, Shanghai, Guangzhou, Shenyang, Xian and Chongqing. Rayfield Technologies has strength at all levels of the Chinese healthcare system.
\"China represents a significant opportunity for the Company. Its population of 1.3 billion has hemorrhoid prevalence rates higher than those reported in North America,\" said Edward Wright, Chief Executive Officer. \"One of the primary reasons we selected Rayfield Technologies as our partner is because they utilize similar physician training and support methodologies that CRH has used to build a successful Partnership Program in North America.\"
Dr. Patrick Xu, Rayfield Technologies founder and CEO states, \"Many people in China suffer from hemorrhoids. The CRH O\'Regan System will provide this extremely underserved market with a safe and effective treatment technology.\" Dr. Mark Noar, advisor and consultant to both the Chinese Academics Committee of Medicine and Rayfield Technologies states, \"We have never experienced such an enthusiastic response to a product demonstration as we did when we demonstrated the CRH O\'Regan System last fall in China.\" Edward Wright further states, \"We will continue to identify partners worldwide that have similar training and support philosophies. We believe China is the first of many new markets where the CRH O\'Regan System will be available in the future.\"